The Central Precocious Puberty (CPP) market centers on therapies designed to halt or delay the onset of puberty in children exhibiting early sexual maturation. Key products include gonadotropin-releasing hormone (GnRH) analogs such as leuprolide acetate, triptorelin, and histrelin implants, which act by suppressing pituitary hormone release and slowing bone maturation. https://zippy-goat-z7kvvr.mystrikingly.com/blog/central-precocious-puberty-market-riseson-innovative-therapies